Katie McGinty Appointed Partner at Militia Hill Ventures

Tuesday, April 18, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

Leading Woman-Owned Life Sciences Venture Firm Builds and Advances High-Growth Companies in Greater Philadelphia

PHILADELPHIA, April 18, 2017 /PRNewswire/ -- Militia Hill Ventures, a firm that creates and grows exceptional life

science companies, announced today that Kathleen A. "Katie" McGinty has joined as a partner. McGinty has an impressive career in the private and public sectors where the development and commercialization of technology has been a top priority and interest coupled with an academic background in chemistry.

"With our focus on identifying transformative science from around the world into promising companies that tap into the vast wealth of talent that Greater Philadelphia offers, Katie McGinty will be a powerful asset for our vision," Militia Hill Ventures Founding Managing Partner Dr. Joan Lau said. "Katie's operational background combined with her national network and first-hand knowledge of the many strengths we have here in Pennsylvania will help us further establish our firm and region as leaders in creating and growing promising new life sciences companies."

"Militia Hill is an accomplished and highly respected team at the cutting edge of transforming promising immunotherapy, gene therapy and other innovations into companies that are positioned to thrive, grow and ultimately deliver relief to patients and cures for devastating diseases," said McGinty. "It is an honor to be part of such urgent and worthwhile work."

McGinty's public sector career includes serving as the first woman to chair the White House Council on Environmental Quality during President Bill Clinton's administration and as Secretary of Environmental Protection under Governor Ed Rendell. McGinty served as Chief of Staff to Governor Tom Wolf and most recently was the Democratic nominee for United States Senate in Pennsylvania. 

McGinty's career in government was launched when she was awarded the Congressional Fellowship of the American Chemical Society and went to work for then-Senator Al Gore developing legislation to strengthen the competitiveness of U.S. high tech companies commercializing basic research.? Just prior, with a degree in chemistry from St. Joseph's University and a law degree from Columbia University, McGinty was awarded a judicial clerkship on the Court of Appeals for the Federal Circuit, the federal appellate court that has special jurisdiction over intellectual property matters.

In addition to her public sector experience, McGinty has had a distinguished career in the private sector, serving as a Director with NRG Energy, as Senior Vice President and Managing Director with Weston Solutions, and as an Operating Partner at clean tech private equity firm, Element Partners. McGinty has extensive experience working with early stage and startup companies, serving as a director or on the advisory board of many young enterprises.

About Militia Hill Ventures Militia Hill Ventures creates and develops transformative life sciences companies in the Philadelphia region. The woman-owned firm takes a hands-on approach with its portfolio companies – including Talee Bio, Immunome and Tcera – often serving in senior management roles in companies they are helping to launch. With a broad network, an impressive track record and domain expertise, Militia Hill brings together cutting-edge science, world-class scientific experts, proven management and successful investors. This proactive approach generates companies capable of developing important new therapies for patients and delivering value to investors. For more information, visit www.militiahillventures.com.

Contact Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/katie-mcginty-appointed-partner-at-militia-hill-ventures-300440800.html

SOURCE Militia Hill Ventures


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store